NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 298 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $216,557 | -32.7% | 12,642 | -38.6% | 0.03% | -24.4% |
Q1 2024 | $321,665 | +74.3% | 20,580 | +66.5% | 0.04% | +13.9% |
Q4 2023 | $184,580 | +317.3% | 12,363 | +351.4% | 0.04% | +176.9% |
Q3 2023 | $44,235 | -23.4% | 2,739 | +96.8% | 0.01% | -27.8% |
Q2 2023 | $57,768 | -32.8% | 1,392 | -2.6% | 0.02% | -37.9% |
Q1 2023 | $85,940 | +9.9% | 1,429 | +34.1% | 0.03% | -6.5% |
Q4 2022 | $78,191 | +4.3% | 1,066 | +8.7% | 0.03% | -3.1% |
Q3 2022 | $75,000 | – | 981 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
StepStone Group LP | 1,365,479 | $29,767,000 | 21.90% |
Tamarack Advisers, LP | 1,115,000 | $24,307,000 | 11.56% |
COURAGE CAPITAL MANAGEMENT LLC | 275,000 | $5,995,000 | 4.57% |
GREAT POINT PARTNERS LLC | 753,481 | $16,426,000,000 | 2.44% |
HARTLINE INVESTMENT CORP/ | 404,052 | $8,808,000 | 2.42% |
Pier Capital, LLC | 346,350 | $7,550,000 | 1.29% |
Rhenman & Partners Asset Management AB | 435,000 | $9,483,000 | 1.17% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,029,910 | $22,452,000 | 0.77% |
PEREGRINE CAPITAL MANAGEMENT LLC | 922,468 | $20,110,000 | 0.49% |
Hodges Capital Management Inc. | 285,500 | $6,224,000 | 0.49% |